Lactostasis and prevention of lactation mastitis: role of neonatologist and pediatrician

Breastfeeding is one of the main components of the health and optimal growth of a newborn child. The article presents recommendations on breastfeeding support in case of lactostasis and mastitis, as well as the role of neonatologist and pediatrician in prevention and preservation of breastfeeding when mother faces problems, lactation support in case of lactational mastitis development in mother. Prolonged lactostasis may be the cause of mastitis - breast inflammation, which is characterized by painfulness, swelling and redness of the breast. If the symptoms persist for 12-24 hours, in conditions of impaired milk evacuation the growth of microorganisms occurs, which leads to infectious lactation mastitis, which may be complicated by an abscess. The main risk factors of mastitis development, various methods of diagnostics, lactostasis and lactation mastitis prophylaxis are considered, and the special role of breastfeeding advice to the mother is emphasized. Data on modern and prospective method of lactostasis and mastitis prophylaxis - application of the product Lactanza based on Lactobacillus fermentum CECT5716 are presented. The use of probiotic bacteria was proposed as a method of modulating the immune system of a developing child to reduce the risk of immune aberrations and improve the immune protection of his or her body. According to the published data, there was a 51% reduction of mastitis frequency in the group that received probiotic Lactobacillus fermentum CECT5716. Therefore, it is advisable for women who start breastfeeding with increased risk factors for lactostasis and mastitis to recommend taking Lactobacillus fermentum CECT5716 probiotic immediately after childbirth during the first month of breastfeeding. The drug is also indicated for treatment of lactostasis in breastfeeding women to prevent mastitis from developing and after antibiotic therapy of mastitis to restore breast microbiome and lower the risk of relapse.

1. Yakovlev Y.Y., Manerov F.K. Lactostasis and lactation mastitis in pediatric practice. Sibirskoe meditsinskoe obozrenie = Siberian Medical Review. 2015;(2):32-41. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=23733107.

2. Pustotina O.A. Breastfeeding - problems and solutions. Ul'yanovskiy mediko-biologicheskiy zhurnal = Ulyanovsk Medico-Biological Journal. 2011;(4):131-139. (In Russ.) Available at: https://elibrary.ru/item.asp?id=17683608.

3. Kvist LJ., Larsson B.W., Hall-Lord M.L., Steen A., Schalen C. The role of bacteria in lactational mastitis and some considerations of the use of antibiotic treatment. Int Breastfeed J. 2008;3:6. doi: 10.1186/1746-4358-3-6.

4. Kinlay J.R., O’Connell D.L., Kinlay S. Risk factors for mastitis in breastfeeding women: results of a prospective cohort study. Aust N Z J Public Health. 2001;25(2):115-120. doi: 10.1111/j.1753-6405.2001.tb01831.x.

5. Stafford I.. Hernandez J.. Laibl V., Sheffield J., Roberts S., Wendel GJr. Community-acquired methicillin-resistant Staphylococcus aureus among patients with puerperal mastitis requiring hospitalization. Obstet Gynecol. 2008;112(3):533-537. doi: 10.1097/AOG.0b013e31818187b0.

6. Committee on Health Care for Underserved Women, American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 361: Breastfeeding: maternal and infant aspects. Obstet Gynecol. 2007;109(2 Pt 1):479-480. doi: 10.1097/00006250-200702000-00064.

7. World Health Organization. Mastitis: Causes and management. 2000. Available at: https://www.who.int/maternal_child_adolescent/documents/fch_cah_00_13/en/

8. Schoenfeld E.M., McKay M.P. Mastitis and methicillin-resistant Staphylococcus aureus (MRSA): the calm before the storm? J Emerg Med. 2010;38(4):31-34. doi: 10.1016/j.jemermed.2008.11.021.

9. Dixon J.M., Khan L.R. Treatment of breast infection. BMJ. 2011;342:d396. doi: 10.1136/bmj.d396.

10. Thomsen A.C, Espersen T, Maigaard S. Course 19. and treatment of milk stasis, noninfectious inflammation of the breast, and infectious mastitis in nursing women. Am J Obstet Gynecol. 1984;149(5):492-495. doi: 10.1016/0002-9378(84)90022-x.

11. Amir L.H. Breast pain in lactating women-mas-titis or something else? Aust Fam Physician. 2003;32(3):141-145. Available at: https//www.20.ncbi.nlm.nih.gov/pubmed/12666351.

12. Spencer J.P. Management of mastitis in breastfeeding women. Am Fam Physician. 2008;78(6):727-731. Available at: https//www.ncbi.nlm.nih.gov/pubmed/18819238.

13. Prachniak G.K. Common breastfeeding problems. Obstet Gynecol Clin North Am. 2002;29(1):77-88. doi: 10.1016/s0889-8545(03)00053-6.

14. Berens P.D. Prenatal, intrapartum, and postpartum support of the lactating mother. Pediatr Clin North Am. 2001;48(2):365-376. doi: 10.1016/s0031-3955(08)70030-0.

15. Kvist LJ., Rydhstroem H. Factors related to abscess after delivery: a populationbased study. BJOG. 2005;112(8):1070-1074. doi: 10.1111/j.1471-0528.2005.00659.x.

16. Dener C., Inan A. Breast abscesses in lactating women. World J Surg. 2003;27(2):130-133. doi: 10.1007/s00268-002-6563-6.

17. Ortiz-Andrellucchi A., Sanchez-Villegas A., Rodriguez-Gallego C., Lemes A., Mjlero N., Soria A. et al. Immunomodulatory effects of the intake of fermented milk with Lactobacillus casei DN114001 inlactating mother sand their children. Br J Nutr. 2008;100(4):834-845. doi: 10.1017/S0007114508959183.

18. Kukkonen K., Savilahti E., Haahtela T., Juntunen- 25. Backman K., Korpela R., Poussa T. et al. Longterm safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics. 2008;122(1):8-12. doi: 10.1542/peds.2007-1192.

19. Hurtado J.A., Maldonado-Lobon J.A., Diaz Ropero M.P., Flores-Rojas K., Uberos J., Leante J.L. et al. Oral Administration to Nursing Women of Lactobacillus fermentum CECT5716 Prevents Lactational Mastitis Development: A Randomized Controlled Trial. Breastfeed Med. 2017;12(4):202-209. doi: 10.1089/bfm.2016.0173.

20. Zakharova I.N., Kuchina А.Е., Berezhnaya I.V. New trends in preserving breastfeeding by use of probiotics to prevent mastitis and lactosta-sis in breastfeeding women. Meditsinskiy sovet = Medical Council. 2019;(17):17-23. (In Russ.) doi: 10.21518/2079-701X-2019-17-17-23.

21. Academy of Breastfeeding Medicine Protocol Committee. ABM clinical protocol #4: mastitis. Revision, May 2008. Breastfeed Med. 2008;3(3):177-180. doi: 10.1089/bfm.2008.9993.

22. Jahanfar S., Ng CJ., Teng C.L. Antibiotics for mastitis in breastfeeding women. Cochrane Database Syst Rev. 2013;(2):CD005458. doi: 10.1002/14651858.CD005458.pub3.

23. Gil-Campos M., Angel Lopez M., Rodriguez-Benitez V., Romero J., Roncero I., Linares D. et al. Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1-6 months of age: A Randomized Controlled Trial. Pharmacological Research. 2012;65(2):231-238. doi: 10.1016/j.phrs.2011.11.016.

24. Maldonado J., Canabate F., Sempere L., Vela F., Sanchez A.R., Narbona E. et al. Human milk probiotic Lactobacillus fermentum CECT5716 reduces the incidence of gastrointestinal and upper respiratory tract infections in infants. J Pediatr Gastroenterol Nutr. 2012;54(1):55-61. doi: 10.1097/MPG.0b013e3182333f18.

25. Arroyo R., Martin V., Maldonado A., Jimenez E., Fernandez L., Rodriguez J.M. Treatment of infectious mastitis during lactation: antibiotics versus oral administration of Lactobacilli isolated from breast milk. Clin Infect Dis. 2010;50(12):1551-1558. doi: 10.1086/652763.